Zai Lab Limited

ZLAB

$25.87

Name : Zai Lab Limited

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $3,201,988,352.00

EPSttm : -1.8

Zai Lab Limited

$25.87

2.12%

$0.56

ZLAB — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

8.44

Margin Of Safety %

Put/Call OI Ratio

3.17

EPS Next Q Diff

EPS Last/This Y

-0.31

EPS This/Next Y

-0.14

Price

26.42

Target Price

34.41

Analyst Recom

1.38

Performance Q

3.69

Upside

-188.0%

Beta

0.69

Ticker: ZLAB

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-12	ZLAB	24.56	2.34	420.00	19107
2026-10-13	ZLAB	23.12	2.35	13.05	19148
2026-10-14	ZLAB	22.49	2.36	36.11	19269
2026-10-15	ZLAB	23.49	2.38	169.13	19428
2026-10-16	ZLAB	23.15	2.52	17.22	20207
2026-10-19	ZLAB	24.06	2.60	5.90	20285
2026-10-20	ZLAB	25.07	2.85	1.43	21941
2026-10-21	ZLAB	24.18	2.90	5.08	22088
2026-10-22	ZLAB	22.04	2.96	152.73	22564
2026-10-23	ZLAB	24.01	2.99	21.47	22732
2026-10-26	ZLAB	24.37	2.99	6.23	23073
2026-10-27	ZLAB	23.56	3.02	999.99	23587
2026-10-28	ZLAB	23.02	3.09	999.99	23995
2026-10-29	ZLAB	22.38	3.10	3.34	24077
2026-10-30	ZLAB	22.11	3.09	19.83	24215
2026-11-02	ZLAB	21.67	3.11	376.33	24397
2026-11-03	ZLAB	21.97	3.15	66.00	24645
2026-11-04	ZLAB	22.83	3.17	61.17	24809
2026-11-05	ZLAB	22.58	3.20	251.20	24983
2026-11-06	ZLAB	25.46	3.23	1.82	25167
2026-11-09	ZLAB	26.86	3.24	0.19	25248
2026-11-10	ZLAB	26.39	3.17	0.11	25438
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-12	ZLAB	24.59	-71.0	-	-2.20
2026-10-13	ZLAB	23.11	-71.0	-	-2.20
2026-10-14	ZLAB	22.49	-71.0	-	-2.20
2026-10-15	ZLAB	23.50	-71.0	-	-2.20
2026-10-16	ZLAB	23.18	-71.0	-	-2.20
2026-10-19	ZLAB	24.04	-71.0	-	-2.20
2026-10-20	ZLAB	24.04	-71.0	-	-2.20
2026-10-21	ZLAB	25.08	-71.0	-	-2.20
2026-10-22	ZLAB	22.04	-71.0	-	-2.20
2026-10-23	ZLAB	24.03	-71.0	-	-2.20
2026-10-26	ZLAB	24.35	-71.0	-	-2.20
2026-10-27	ZLAB	23.57	-71.0	-	-2.20
2026-10-28	ZLAB	23.01	-71.0	-	-2.20
2026-10-29	ZLAB	22.36	-71.0	-	-2.20
2026-10-30	ZLAB	22.11	-71.0	-	-2.20
2026-11-02	ZLAB	21.67	-71.0	-	-2.20
2026-11-03	ZLAB	21.97	-71.0	-	-2.20
2026-11-04	ZLAB	22.83	-79.3	-	-2.20
2026-11-05	ZLAB	22.59	-79.3	-	-2.20
2026-11-06	ZLAB	25.48	-79.3	-	-2.20
2026-11-09	ZLAB	26.88	-79.3	-	-2.20
2026-11-10	ZLAB	26.42	-27.6	-	-1.91
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-12	ZLAB	-3.11	-5.24	6.82
2026-10-13	ZLAB	-3.11	-5.24	6.82
2026-10-14	ZLAB	-3.11	-5.24	6.82
2026-10-15	ZLAB	-3.11	-5.24	6.82
2026-10-16	ZLAB	-3.11	-5.24	6.82
2026-10-19	ZLAB	-3.11	-4.51	6.82
2026-10-20	ZLAB	-3.11	-4.51	6.82
2026-10-21	ZLAB	-3.11	-4.51	6.82
2026-10-22	ZLAB	-3.11	-4.51	6.82
2026-10-23	ZLAB	-3.11	-4.51	6.82
2026-10-26	ZLAB	-3.11	-5.52	6.82
2026-10-27	ZLAB	-3.11	-5.52	8.44
2026-10-28	ZLAB	-3.11	-5.52	8.44
2026-10-29	ZLAB	-3.11	-5.52	8.44
2026-10-30	ZLAB	-3.11	-5.52	8.44
2026-11-02	ZLAB	-3.11	-3.37	8.44
2026-11-03	ZLAB	-3.11	-3.37	8.44
2026-11-05	ZLAB	-3.11	-3.37	8.44
2026-11-06	ZLAB	-3.11	-3.37	8.44
2026-11-09	ZLAB	-3.11	-0.07	8.44
2026-11-10	ZLAB	-3.11	-0.07	8.44
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

-0.59

Avg. EPS Est. Next Quarter

-0.53

Insider Transactions

-3.11

Institutional Transactions

-0.07

Beta

0.69

Average Sales Estimate Current Quarter

102

Average Sales Estimate Next Quarter

116

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

71.2

Max Drawdown 5-Year %

-84.9

Target Price

34.41

P/E

Forward P/E

PEG

P/S

6.73

P/B

5.28

P/Free Cash Flow

EPS

-1.79

Average EPS Est. Cur. Y

-1.91

EPS Next Y. (Est.)

-2.05

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-44.91

Relative Volume

1.35

Return on Equity vs Sector %

-61.5

Return on Equity vs Industry %

-41.8

EPS 1 7Days Diff

0.3

EPS 1 30Days Diff

0.29

EBIT Estimation

◆ ZLAB Healthcare

$26.43

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

20/20

Pullback

10/25

Volume

3/15

Valuation

9/20

TP/AR

2/10

Options

3/10

RSI

60.8

Range 1M

67.3%

Sup Dist

🚀

Momentum Growth

Ride accelerating trends

WEAK

Momentum

19/25

Growth

6/30

Estimates

2/20

Inst/Vol

4/15

Options

6/10

EPS Yr

-32.7%

EPS NY

3.5%

52W%

80.9%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +30.2% upside

Quality

5/30

Valuation

10/30

Growth

2/25

Stability

6/10

LT Trend

4/5

Upside

+30.2%

Quality

ZLAB — P/E HistoricalBiotechnology

Zai Lab Limited

Sector: Healthcare

Industry: Biotechnology

Employees: 1784

Zai Lab Limited, a biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases. Its commercial products include Zejula, an orally administered poly (ADP-ribose) polymerase 1/2 inhibitor for treating ovarian cancer; VYVGART, a human IgG1 antibody fragment for generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy; NUZYRA for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections; Optune for glioblastoma multiforme; Qinlock for gastrointestinal stromal tumors; Xacduro for treating hospital-acquired and ventilator-associated bacterial pneumonia caused by a cinetobacter baumannii-calcoaceticus complex; and Augtyro for the treatment of ROS proto-oncogene 1 and non-small cell lung cancer. The company has a strategic collaboration with Tesaro, Inc., NovoCure Ltd., Deciphera Pharmaceuticals, LLC, Paratek Bermuda Ltd., argent BV, Turning Point Therapeutics, Inc., Entasis Therapeutics Holdings Inc., Karuna Therapeutics, Inc., Pfizer Inc., Amgen Inc., and with Boehringer Ingelheim GmbH. The company was incorporated in 2013 and is based in Pudong, China.

ZLAB

Latest News

—

Caricamento notizie per ZLAB…

stock quote shares ZLAB – Zai Lab Limited Stock Price stock today

news today ZLAB – Zai Lab Limited stock forecast ,stock prediction 2023 2024 2025

marketwatch ZLAB – Zai Lab Limited yahoo finance google finance

stock history ZLAB – Zai Lab Limited invest stock market

stock prices ZLAB premarket after hours

ticker ZLAB fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ZLAB

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y